NOVUS THERAPEUTICS INC's ticker is NVUS and the CUSIP is 67011N105. A total of 17 filers reported holding NOVUS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $201,000 | -38.7% | 324,383 | 0.0% | 0.02% | -46.4% |
| Q2 2019 | $328,000 | -74.8% | 324,383 | 0.0% | 0.03% | -81.5% |
| Q1 2019 | $1,304,000 | +151.3% | 324,383 | 0.0% | 0.15% | +135.9% |
| Q4 2018 | $519,000 | -65.7% | 324,383 | 0.0% | 0.06% | -61.9% |
| Q3 2018 | $1,515,000 | -33.3% | 324,383 | 0.0% | 0.17% | -34.6% |
| Q2 2018 | $2,271,000 | +38.9% | 324,383 | 0.0% | 0.26% | +46.9% |
| Q1 2018 | $1,635,000 | – | 324,383 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,537,110 | $4,059,000 | 0.08% |
| Boxer Capital, LLC | 324,383 | $519,000 | 0.06% |
| B. Riley Wealth Advisors, Inc. | 120,219 | $193,000 | 0.03% |
| CARY STREET PARTNERS INVESTMENT ADVISORY LLC | 10,600 | $22,000 | 0.02% |
| Sequoia Financial Advisors, LLC | 22,500 | $36,000 | 0.00% |
| VANGUARD GROUP INC | 42,403 | $68,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 10,944 | $18,000 | 0.00% |
| UBS Group AG | 1,061 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 23,424 | $36,000 | 0.00% |